GENEVA, April 27 -- ZHEJIANG YANGLI PHARMACEUTICAL TECHNOLOGY CO., LTD. (Room 1106, Building 1, Haozhang Plaza, Gongshu DistrictHangzhou, Zhejiang 310024), 浙江扬厉医药技术有限公司 (中国浙江省杭州市拱墅区皓章大厦1幢1106室) filed a patent application (PCT/CN2025/128572) for "DOUBLE-STRANDED SIRNA FOR INHIBITING C3 EXPRESSION AND CONJUGATE THEREOF" on Oct 17, 2025. With publication no. WO/2026/082188, the details related to the patent application was published on Apr 23, 2026.
Notably, the patent application was submitted under the International Patent Classification (IP...